[2] There are a number of disorders associated with chronic mucocutaneous candidiasis including endocrine dysfunctions, vitiligo, malabsorption syndromes, neoplasms, and others.

In most patients, chronic mucocutaneous candidiasis is correlated to abnormalities in cell-mediated immunity (T-lymphocyte mediated response)[citation needed].

Current effective treatments include anti-fungal drugs and, for long-term remissions, restoration of cellular immunity.

[6] Patients with autosomal-dominant mucocutaneous candidiasis may be at risk for epidermoid esophageal cancer due to the nitrosamine compounds produced by chronic candida infections.

[9][10] Chronic mucocutaneous candidiasis can be diagnosed in an affected individual via the following methods/tests:[3][4] Management for an individual with chronic mucocutaneous candidiasis consists of the following (relapse occurs once treatment is ceased, in many cases):[4][11] ^ Indicates 9 references to specific, numbered pages in the Online Mendelian Inheritance in Man database.